AL
Astellas Pharma Inc.
ALPMY · OTC
$15.43 +1.45% (+$0.22)
1M +2.20%
Market Cap ¥4.36T
P/E Ratio 11.34x
Div. Yield 2.84%
ROE 21.43%
Bulios Fair Price
$14.08
8.7% downside
Trenutna cena
$15.43
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ALPMY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
92 /100
Cheap P/E 11.34x
EV/EBITDA 8.84x
P/S 1.81x
Growth
91 /100
Growing EPS growth 47.21%
Rev. growth 14.31%
FCF growth 30.29%
Profitability
95 /100
Strong Gross margin 73.34%
Net margin 15.93%
Op. margin 22.33%
Quality
84 /100
Excellent ROIC 15.34%
ROE 21.43%
ROA 10.47%
Debt
91 /100
Low Debt/Equity 0.30x
Current ratio 1.20x
Int. coverage 38.20x
Stability
45 /100
Moderate Beta 0.09x
Rev. volatility 7.70%
EPS volatility 296.92%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ALPMY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Naoki Okamura
Employees
14,099
Headquarters
Tokyo
Prihajajoči dogodki
29 SEP.
Ex-Dividend
Ex-dividend date
29 OKT.
Earnings
Upcoming earnings report
01 DEC.
Dividend Payment
Datum plačila